Cargando…
Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention
OBJECTIVES: Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) was identified in late 2019, spreading to over 200 countries and resulting in almost two million deaths worldwide. The emergence of safe and effective vaccines provides a route out of the pandemic, with vaccination uptake of 75–90% need...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society for Public Health. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520885/ https://www.ncbi.nlm.nih.gov/pubmed/34801843 http://dx.doi.org/10.1016/j.puhe.2021.10.006 |
_version_ | 1784584775990771712 |
---|---|
author | Knight, H. Jia, R. Ayling, K. Bradbury, K. Baker, K. Chalder, T. Morling, J.R. Durrant, L. Avery, T. Ball, J.K. Barker, C. Bennett, R. McKeever, T. Vedhara, K. |
author_facet | Knight, H. Jia, R. Ayling, K. Bradbury, K. Baker, K. Chalder, T. Morling, J.R. Durrant, L. Avery, T. Ball, J.K. Barker, C. Bennett, R. McKeever, T. Vedhara, K. |
author_sort | Knight, H. |
collection | PubMed |
description | OBJECTIVES: Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) was identified in late 2019, spreading to over 200 countries and resulting in almost two million deaths worldwide. The emergence of safe and effective vaccines provides a route out of the pandemic, with vaccination uptake of 75–90% needed to achieve population protection. Vaccine hesitancy is problematic for vaccine rollout; global reports suggest only 73% of the population may agree to being vaccinated. As a result, there is an urgent need to develop equitable and accessible interventions to address vaccine hesitancy at the population level. STUDY DESIGN: & Method: We report the development of a scalable digital intervention seeking to address COVID-19 vaccine hesitancy and enhance uptake of COVID-19 vaccines in the United Kingdom. Guided by motivational interviewing (MI) principles, the intervention includes a series of therapeutic dialogues addressing 10 key concerns of vaccine-hesitant individuals. Development of the intervention occurred linearly across four stages. During stage 1, we identified common reasons for COVID-19 vaccine hesitancy through analysis of existing survey data, a rapid systematic literature review, and public engagement workshops. Stage 2 comprised qualitative interviews with medical, immunological, and public health experts. Rapid content and thematic analysis of the data provided evidence-based responses to common vaccine concerns. Stage 3 involved the development of therapeutic dialogues through workshops with psychological and digital behaviour change experts. Dialogues were developed to address concerns using MI principles, including embracing resistance and supporting self-efficacy. Finally, stage 4 involved digitisation of the dialogues and pilot testing with members of the public. DISCUSSION: The digital intervention provides an evidence-based approach to addressing vaccine hesitancy through MI principles. The dialogues are user-selected, allowing exploration of relevant issues associated with hesitancy in a non-judgmental context. The text-based content and digital format allow for rapid modification to changing information and scalability for wider dissemination. |
format | Online Article Text |
id | pubmed-8520885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Royal Society for Public Health. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85208852021-10-18 Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention Knight, H. Jia, R. Ayling, K. Bradbury, K. Baker, K. Chalder, T. Morling, J.R. Durrant, L. Avery, T. Ball, J.K. Barker, C. Bennett, R. McKeever, T. Vedhara, K. Public Health Original Research OBJECTIVES: Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) was identified in late 2019, spreading to over 200 countries and resulting in almost two million deaths worldwide. The emergence of safe and effective vaccines provides a route out of the pandemic, with vaccination uptake of 75–90% needed to achieve population protection. Vaccine hesitancy is problematic for vaccine rollout; global reports suggest only 73% of the population may agree to being vaccinated. As a result, there is an urgent need to develop equitable and accessible interventions to address vaccine hesitancy at the population level. STUDY DESIGN: & Method: We report the development of a scalable digital intervention seeking to address COVID-19 vaccine hesitancy and enhance uptake of COVID-19 vaccines in the United Kingdom. Guided by motivational interviewing (MI) principles, the intervention includes a series of therapeutic dialogues addressing 10 key concerns of vaccine-hesitant individuals. Development of the intervention occurred linearly across four stages. During stage 1, we identified common reasons for COVID-19 vaccine hesitancy through analysis of existing survey data, a rapid systematic literature review, and public engagement workshops. Stage 2 comprised qualitative interviews with medical, immunological, and public health experts. Rapid content and thematic analysis of the data provided evidence-based responses to common vaccine concerns. Stage 3 involved the development of therapeutic dialogues through workshops with psychological and digital behaviour change experts. Dialogues were developed to address concerns using MI principles, including embracing resistance and supporting self-efficacy. Finally, stage 4 involved digitisation of the dialogues and pilot testing with members of the public. DISCUSSION: The digital intervention provides an evidence-based approach to addressing vaccine hesitancy through MI principles. The dialogues are user-selected, allowing exploration of relevant issues associated with hesitancy in a non-judgmental context. The text-based content and digital format allow for rapid modification to changing information and scalability for wider dissemination. The Royal Society for Public Health. Published by Elsevier Ltd. 2021-12 2021-10-18 /pmc/articles/PMC8520885/ /pubmed/34801843 http://dx.doi.org/10.1016/j.puhe.2021.10.006 Text en © 2021 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Research Knight, H. Jia, R. Ayling, K. Bradbury, K. Baker, K. Chalder, T. Morling, J.R. Durrant, L. Avery, T. Ball, J.K. Barker, C. Bennett, R. McKeever, T. Vedhara, K. Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention |
title | Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention |
title_full | Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention |
title_fullStr | Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention |
title_full_unstemmed | Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention |
title_short | Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention |
title_sort | understanding and addressing vaccine hesitancy in the context of covid-19: development of a digital intervention |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520885/ https://www.ncbi.nlm.nih.gov/pubmed/34801843 http://dx.doi.org/10.1016/j.puhe.2021.10.006 |
work_keys_str_mv | AT knighth understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention AT jiar understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention AT aylingk understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention AT bradburyk understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention AT bakerk understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention AT chaldert understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention AT morlingjr understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention AT durrantl understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention AT averyt understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention AT balljk understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention AT barkerc understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention AT bennettr understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention AT mckeevert understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention AT vedharak understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention |